Arrowhead Pharmaceuticals raises $700 million in convertible notes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St futures flat after tech rout; Iran tensions, retail earnings in focus
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Global bond rout pauses as sovereign yields back off multi-decade highs
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 12
January 12, 2026 5:01 PM ESTfalse 0000879407 0000879407 2026-01-12 2026-01-12... More
Form 8-K ARROWHEAD PHARMACEUTICAL For: Jan 07
January 9, 2026 6:02 AM ESTfalse 0000879407 0000879407 2026-01-07 2026-01-07... More
